ESC Premium Access

GLP-1 receptor agonists: the cardiovascular benefits beyond glucose control.

Topic: Risk Factors and Prevention
Organised by PACE-CME, Physicians' Academy for Cardiovascular Education, supported with an educational grant from Novo Nordisk

Congress Presentation

About the speaker

Professor Filip Krag Knop

Gentofte Hospital, University of Copenhagen, Copenhagen (Denmark)
4 presentations
0 follower

4 more presentations in this session

Introduction - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?

Speaker: Professor T. Luscher (London, GB)

Thumbnail

Diabetes and cardiovascular disease: time for a multifactorial approach.

Speaker: Professor J. Deanfield (London, GB)

Thumbnail

Translating GLP-1 trial outcomes to cardiology practice: which patients will benefit? .

Speaker: Professor L. Ryden (Stockholm, SE)

Thumbnail

Discussion and summary - Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice?

Speaker: Professor T. Luscher (London, GB) Professor J. Deanfield (London, GB)

Thumbnail

Access the full session

Outcomes of GLP-1 RA in diabetes and cardiovascular disease: what are the key opportunities for cardiology practice? (EBAC Accredited)

Speakers: Professor F. Krag Knop, Professor T. Luscher, Professor J. Deanfield, Professor L. Ryden, Professor T. Luscher...
Thumbnail

About the event

Image

ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by